April 17, 2016 -
There has been a recent research paper published in the American Journal of Psychiatry in which a novel treatment has resulted in 66% percent response rate in serious, treatment resistant depression.
This should bring fresh hope to the many patients who are burdened down with depression and can see no hope. The research needs to be repeated by another independent team to confirm (or refute) the findings, but these results are striking. The medication is used regularly for a different condition but does not have a licence for the treatment of depression in the UK. That does not mean that it cannot be prescribed and used with informed consent by a specialist in the field. Please contact 96 Harley Street on 02074860506 if you wish to have an assessment?
Share this story on: